4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001209191-23-052780
Options or other derivatives
- VP of Strategy and Finance acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Maestas Nicholas VP of Strategy and Finance | 2023-10-11 | Grant or award · Employee Stock Option (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X05/doc4.xml…